1. Konstas AG, Quaranta L, Bozkurt B, et al. 24-h Efficacy of Glaucoma Treatment Options [published correction appears in Adv Ther. 2016 Apr;33(4):518]. Adv Ther. 2016;33(4):481–517. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846688/pdf/12325_2016_Article_302.pdf 2. Li F, Huang W, Zhang X. Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis. Acta Ophthalmol. 2018;96(3):e277–e284. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947254/pdf/AOS-96-e277.pdf 3. Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27(11):1293–1298. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831141/pdf/eye2013187a.pdf 4. Asiedu K, Abu SL. The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review. J Curr Ophthalmol. 2018;31(1):8-15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407091/pdf/main.pdf 5. Sleath B, Blalock SJ, Carpenter DM, et al. Provider Education about Glaucoma and Glaucoma Medications during Videotaped Medical Visits. J Ophthalmol. 2014;2014:238939. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020294/pdf/JOPH2014-238939.pdf 6. Tapply I, Broadway DC. Improving Adherence to Topical Medication in Patients with Glaucoma. Patient Prefer Adherence. 2021 Jul 2;15:1477-1489. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259615/pdf/ppa-15-1477.pdf